Skip to content

Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy

Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07522268
Enrollment
84
Registered
2026-04-13
Start date
2019-06-01
Completion date
2021-01-01
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulpotomy

Brief summary

Diode lasers could be a viable alternative to ferric sulphate in pulpotomy.

Detailed description

Ferric sulphate (FS) has recently replaced formocresol as it has comparable clinical and radiographic outcomes, and is more biocompatible, making it the current material of choice. 6,7 However, some histological studies report inflammatory response caused by FS in the remaining pulp, similar to FC, which may lead to internal resorption and eventually, premature tooth exfoliation. In contrast to ferric sulphate, diode lasers due to their better antimicrobial action, cell regenerative properties, localized/controlled, and quick mechanism of action, are now being considered as an effective method of pulpotomy in dentistry. Even with several studies that have been conducted on the efficacy and success of laser pulpotomy, there is still a need for additional data and evidence that would further advocate its use in pulpotomy. Furthermore, there hasn't been any such study conducted in this region, which also highlights the importance of this study.

Interventions

PROCEDUREGroup B (Diode Laser)

Group B (Diode Laser)

COMBINATION_PRODUCT(Ferric Sulphate)

After hemostasis was achieved a sterile cotton pellet soaked in 15.5% ferric sulphate solution (Quickstat-FS, USA) was placed over amputated root stumps for 15-20 seconds.

Sponsors

Shaheed Zulfiqar Ali Bhutto Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
4 Years to 8 Years
Healthy volunteers
Yes

Inclusion criteria

* Primary molars( either mandibular or maxillary or both) of children in the age range of 4 to 8 years. * Absence of spontaneous pain, associated swelling, tenderness to percussion, pathological mobility, sinus tract

Exclusion criteria

* Periapical Abscess * Necrotic pulp * Teeth nearing exfoliation * Non cooperative patients * Patients with poor oral hygiene * Parents/patients not willing to be a part of study * Any drug allergies * Any medical history contraindicating the pulp treatment

Design outcomes

Primary

MeasureTime frameDescription
Presence of Pain or tenderness or mobility1,3,6,9, and 12 months intervalsTeeth will be scored as clinical success if they had absence of pain, tenderness, pathological mobility, and sinus or abscess formation. Presence of any of these signs and symptoms will be scored as clinical failure.
Presence of resorption or periapical pathology1,3,6,9 and 12 months intervalRadiographic assessment included evaluation of pathological external or internal root resorption, periapical or inter-radicular radiolucency and widening of the periodontal ligament (PDL). Presence of any of these signs on the periapical radiograph will be recorded as a radiographic failure.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026